On Thursday, Moderna Inc (MRNA) stock saw a decline, ending the day at $52.8 which represents a decrease of $-0.59 or -1.11% from the prior close of $53.39. The stock opened at $53.39 and touched a ...

Northwestern filed a lawsuit against Moderna Wednesday alleging the company misused the University’s patented lipid ...

A year after the first samRNA vaccine approval, experts say similar vaccines in development are likely to face scientific and ...

In an era where viral outbreaks can escalate into global pandemics with alarming speed, the ability to quickly develop new ...

The discovery of the first mRNA-stabilizing substance could pave the way for groundbreaking advancements in the development ...

A new vaccine that could stop people from developing the vomiting bug norovirus is on trial in the UK. The mRNA vaccine from ...

Study reveals single-chain mRNA vaccines confer 100% protection against lethal mpox challenge in mice, marking a significant ...

Researchers are developing what they hope will be the first successful vaccine against the highly contagious and difficult-to ...

A single COVID-19 mRNA vaccine dose provided similar protection to that conferred by a 2-dose series among immunocompetent patients aged 5 years and older.

A new vaccine provides hope for treating and even preventing the highly contagious and difficult-to-treat Clostridioides ...

▎药明康德内容团队编辑（来源：中国科学院动物研究所）mRNA疗法因研发周期短、生产成本低、制备工艺简单、起效快等优势，被广泛应用于疫苗研发、蛋白替代疗法和基因编辑等领域。脂质纳米颗粒（LNP）是目前递送mRNA的最佳载体之一，但LNP的靶向递送能力存 ...

站在mRNA技术历史与未来的交汇点上交叉点上，杭州医学所的全体科研人员想要成为驾马车的人，把握分子医学在中国的前进方向。这份“冲动”并非为了金钱与名利，而是想要从分子的层面真正地、彻底地解决中国人民乃至人类的疾苦。